- Home
- / Medicenna Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Medicenna Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.6
2024-10-29
Market Capitalization
$122.2 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | 1.2M | |||||||
| Operating expense total | 7.4M | 4.7M | 8.2M | 17.4M | 22.4M | 16.3M | 18.7M | 21.6M |
| Depreciation and amortization | 10.0K | 7.0K | 8.0K | 40.0K | 37.0K | 5.0K | 5.0K | 55.0K |
| EBITDA | (7.4M) | (4.7M) | (8.2M) | (17.4M) | (22.4M) | (16.3M) | (18.7M) | (20.4M) |
| EBIT | (7.4M) | (4.7M) | (8.2M) | (17.4M) | (22.5M) | (16.3M) | (18.7M) | (20.4M) |
| Interest income | 3.0K | 69.0K | 914.0K | 1.2M | 1.4M | |||
| Pre tax profit | (7.5M) | (4.7M) | (8.3M) | (17.3M) | (22.6M) | (10.0M) | (25.5M) | (11.8M) |
| Net Income | (7.5M) | (4.7M) | (8.3M) | (17.3M) | (22.6M) | (10.0M) | (25.5M) | (11.8M) |